Cancer Therapeutics Market to Accrue $178.86 Bn, Globally, by 2023 at 11.9% CAGR, Says ... - 0 views
-
shawnandrew on 12 Apr 19Prevalence of cancer is on the rise throughout the world. Advanced therapeutics are being developed by pharmaceutical companies to address the growing burden of cancer. The time and costs associated with oncology drug development are also increasing; hence the key companies are collaborating with other pharmaceutical companies to reduce these costs.